Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, agosto 22
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Lucid Diagnostics Inc
LUCD
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.9643
0.0039
0.41%
al cierre: Aug 21, 5:00 PM EST
$0.9800
0.0157
1.63%
After hour: 4:53 PM EST
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Lucid Diagnostics Financials
Lucid Diagnostics (LUCD) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Lucid Diagnostics Q2 Adj. EPS $(0.08) Misses $(0.07) Estimate, Sales $1.474M Miss $1.943M Estimate
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 33.33 percent. This is a 20 percent increase over losses of $(0.10) per share from
Benzinga Newsdesk
Lucid Diagnostics Misses On Revenue, But 2026 Growth Outlook Lights Up Bull Case
Lucid Diagnostics reported Q1 revenue miss. Analyst significant expects revenue growth in 2026/27. Raises PT to $9.25.
Priya Nigam
PRO
Lucid Diagnostics Q1 Adj. EPS $(0.07) Beats $(0.08) Estimate
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 56.25 percent increase over losses of $(0.16) per share from
Benzinga Newsdesk
Earnings Scheduled For May 14, 2026
Benzinga Insights
PRO
Lucid Diagnostics Q1 Sales $1.256M Miss $1.383M Estimate
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly sales of $1.256 million which missed the analyst consensus estimate of $1.383 million by 9.18 percent. This is a 57.00 percent increase over sales of $800.000 thousand
Benzinga Newsdesk
PRO
Lucid Diagnostics Q4 Adj. EPS $(0.10), Inline, Sales $1.504M Beat $1.379M Estimate
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 47.37 percent increase over losses of $(0.19) per share from the same period last year.
Benzinga Newsdesk
Privacy Manager